Linkedin-in

Investor Relations

Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery. 

SEC Filings

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQLPCN
YearTrailing 12-MonthsCalendar Year 2026Calendar Year 2025Calendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
S-1/AAmended Registration statement for face-amount certificate companiesDec 29, 2011Open Amended Registration statement for face-amount certificate companies in HTML.Open Amended Registration statement for face-amount certificate companies in DOC file.Open Amended Registration statement for face-amount certificate companies in PDF file.Open Amended Registration statement for face-amount certificate companies in XLS file.
UPLOADCorrespondence from the SEC to the FilerDec 27, 2011Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
S-1Registration statement for face-amount certificate companiesNov 30, 2011Open Registration statement for face-amount certificate companies in HTML.Open Registration statement for face-amount certificate companies in DOC file.Open Registration statement for face-amount certificate companies in PDF file.Open Registration statement for face-amount certificate companies in XLS file.

Innovating beyond boundaries for patients

Krista Fogarty phone: (801) 994-7383 email: kf@lipocine.com